Ischaemic heart diseases. Ischaemic heart diseases
Conditions
Interventions
Intervention 1: Intervention: In Co-Enzyme Q10 group, all patients will receive totally 300 mg Co-Enzyme Q10 before PCI. Intervention 2: Control: In the control group, Co-Enzyme Q10 will not be admini
Treatment - Drugs
Intervention: In Co-Enzyme Q10 group, all patients will receive totally 300 mg Co-Enzyme Q10 before PCI.
Control: In the control group, Co-Enzyme Q10 will not be administrated. two groups will be given standard treatment.
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences.
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: ischemic heart diseases patients; Aged 18-80; undergoing of angioplasty; stent insertion; filling of consent form. Exclusion Criteria: elevation of CK-MB and cTnI 48 hours before PCI; history of CABG during last three months, history of previous MI; Renal dysfunction (creatinine above 2.5 mg/dl); unsuccessful PCI; Acute MI; cardiogenic shock; dialysis; Pregnancy; inability in filling and understanding of the consent form; unconsented patients; patients who want to discontinue the study at any time.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CK-MB level. Timepoint: 12 hours before and 8 and 24 hours after angioplasty. Method of measurement: ELISA kits.;CTnI level. Timepoint: 12 hours before and 8 and 24 hours after angioplasty. Method of measurement: ELISA kits. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed